The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from a phase II study of eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab in patients with PD-L1 unselected metastatic non-small cell lung carcinoma.
 
Timothy Dudley Clay
No Relationships to Disclose
 
Margarita Majem
No Relationships to Disclose
 
Enriqueta Felip
No Relationships to Disclose
 
Bernard Doger
No Relationships to Disclose
 
Enric Carcereny Costa
No Relationships to Disclose
 
Martin Forster
No Relationships to Disclose
 
Matthew Krebs
No Relationships to Disclose
 
Julio Antonio Peguero
No Relationships to Disclose
 
Christian Mueller
No Relationships to Disclose
 
Frederic Triebel
No Relationships to Disclose